市場調查報告書
商品編碼
1468391
2024-2032 年按服務(手術、診斷測試和影像、身體健康監測等)、動物類型(伴侶動物、農場動物)、最終用途(獸醫診所、獸醫醫院)和地區分類的獸醫服務市場報告Veterinary Service Market Report by Service (Surgery, Diagnostic Tests and Imaging, Physical Health Monitoring, and Others), Animal Type (Companion Animal, Farm Animal), End Use (Veterinary Clinic, Veterinary Hospital), and Region 2024-2032 |
2023年全球獸醫服務市場規模達1,131億IMARC Group。
獸醫服務用於動物疾病、人畜共患病和食源性人畜共患病的監測、早期診斷和治療。它依靠獸藥產品(例如抗菌劑)來最大限度地減少動物源性食品中獸藥殘留和抗菌素抗藥性(AMR)產生的不合規可能性。除此之外,它還有助於提高人們對食品生產商、加工商和分銷商的認知,並解決動物生產食品安全問題。
隨著源自動物的人類病原體數量不斷增加,獸醫服務對於保護動物、保障公眾健康和確保食品安全變得越來越重要。這與世界各地擴大採用伴侶動物結合,是刺激市場成長的關鍵因素之一。此外,由於冠狀病毒病(COVID-19)的爆發,許多國家的政府正在放寬遠距醫療和獸醫-客戶-患者關係(VCPR)法規,並向寵物父母提供遠距醫療。它在獸醫中用於術後檢查、皮膚病學問題、行為問題以及對患有慢性疾病的寵物進行定期隨訪,從而允許獸醫在不直接檢查寵物的情況下開出治療處方。再加上最近寵物服務的擴張,包括線上寵物藥局以及透過訂閱服務提供食品和產品,正在推動市場成長。除此之外,動物健康生物技術的進步,如疫苗、抗菌藥物和診斷工具,可最大限度地減少疾病負擔並提高動物健康和福利標準,正在對市場產生積極影響。此外,預計畜牧業的顯著成長將為未來幾年的市場創造積極的前景。
The global veterinary service market size reached US$ 113.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 170.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.
A veterinary service is utilized in the surveillance, early diagnosis, and treatment of animal diseases, zoonoses, and foodborne zoonotic hazards. It relies on veterinary medicinal products, such as antimicrobial agents, to minimize the likelihood of non-compliance concerning veterinary drug residues in food of animal origin and the development of antimicrobial resistance (AMR). Besides this, it assists in increasing awareness about food producers, processors and distributors, and addressing animal production food safety.
With the rising number of human pathogens originating in animals, veterinary services are presently becoming increasingly essential for protecting animals, safeguarding public health, and ensuring food safety. This, in confluence with the increasing adoption of companion animals around the world, represents one of the key factors stimulating the growth of the market. Moreover, governments of numerous countries are relaxing the telemedicine and veterinarian-client-patient relationship (VCPR) regulations on account of the coronavirus disease (COVID-19) outbreak and making telemedicine available to pet parents. It is utilized in veterinary for postoperative checks, dermatologic concerns, behavioral issues, and scheduled follow-up visits for pets with chronic diseases, thereby allowing veterinarians to prescribe the treatment without the direct examination of pets. This, coupled with recent expansions in pet services, including online pet pharmacies and food and product delivery via subscription services, is impelling the market growth. Apart from this, advances in animal health biotechnologies, such as vaccines, antimicrobials, and diagnostic tools, for minimizing the burden of diseases and improving the standards of animal health and welfare are positively influencing the market. In addition, significant growth in the livestock sector is projected to create a positive outlook for the market in the upcoming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary service market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on service, animal type, and end use.
Surgery
Diagnostic Tests and Imaging
Physical Health Monitoring
Others
Companion Animal
Farm Animal
Veterinary Clinic
Veterinary Hospital
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Addison Biological Laboratory Inc., Armor Animal Health, CityVet, CVS Group PLC, Elanco Animal Health Incorporated, Ethos Veterinary Health LLC, FirstVet, Greencross Vets, Heska Corporation, Idexx Laboratories Inc., Intervet Inc. (Merck & Co. Inc.), PetIQ LLC and Pets at Home Group PLC.